ATE355821T1 - Multiphasensystem - Google Patents

Multiphasensystem

Info

Publication number
ATE355821T1
ATE355821T1 AT98936136T AT98936136T ATE355821T1 AT E355821 T1 ATE355821 T1 AT E355821T1 AT 98936136 T AT98936136 T AT 98936136T AT 98936136 T AT98936136 T AT 98936136T AT E355821 T1 ATE355821 T1 AT E355821T1
Authority
AT
Austria
Prior art keywords
carrier phase
relates
preparations
phase
multiphase system
Prior art date
Application number
AT98936136T
Other languages
English (en)
Inventor
Roland Bodmeier
Original Assignee
Roland Bodmeier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE1997124784 external-priority patent/DE19724784A1/de
Priority claimed from DE1998111951 external-priority patent/DE19811951A1/de
Application filed by Roland Bodmeier filed Critical Roland Bodmeier
Application granted granted Critical
Publication of ATE355821T1 publication Critical patent/ATE355821T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Medicinal Preparation (AREA)
  • Vehicle Body Suspensions (AREA)
AT98936136T 1997-06-05 1998-06-05 Multiphasensystem ATE355821T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE1997124784 DE19724784A1 (de) 1997-06-05 1997-06-05 Verfahren zur in-situ Herstellung von Partikeln
DE1998111951 DE19811951A1 (de) 1998-03-13 1998-03-13 Multiphasen-Systeme

Publications (1)

Publication Number Publication Date
ATE355821T1 true ATE355821T1 (de) 2007-03-15

Family

ID=26037368

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98936136T ATE355821T1 (de) 1997-06-05 1998-06-05 Multiphasensystem

Country Status (9)

Country Link
US (1) US7303756B1 (de)
EP (1) EP0996426B1 (de)
AT (1) ATE355821T1 (de)
AU (1) AU8530498A (de)
DE (1) DE59813940D1 (de)
DK (1) DK0996426T3 (de)
ES (1) ES2284211T3 (de)
PT (1) PT996426E (de)
WO (1) WO1998055100A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE50112157D1 (de) * 2000-01-11 2007-04-19 Roland Bodmeier Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
US9080146B2 (en) 2001-01-11 2015-07-14 Celonova Biosciences, Inc. Substrates containing polyphosphazene as matrices and substrates containing polyphosphazene with a micro-structured surface
US20040191301A1 (en) * 2003-03-27 2004-09-30 Van Duren Albert Philip Transdermal device having a phase change material
US20210299056A9 (en) 2004-10-25 2021-09-30 Varian Medical Systems, Inc. Color-Coded Polymeric Particles of Predetermined Size for Therapeutic and/or Diagnostic Applications and Related Methods
US9107850B2 (en) 2004-10-25 2015-08-18 Celonova Biosciences, Inc. Color-coded and sized loadable polymeric particles for therapeutic and/or diagnostic applications and methods of preparing and using the same
ATE503465T1 (de) 2004-10-25 2011-04-15 Celonova Biosciences Germany Gmbh Beladbare polyphosphazenhaltige teilchen für therapeutische und/oder diagnostische anwendungen sowie herstellungs- und verwendungsverfahren dafür
US9114162B2 (en) 2004-10-25 2015-08-25 Celonova Biosciences, Inc. Loadable polymeric particles for enhanced imaging in clinical applications and methods of preparing and using the same
US7241805B2 (en) * 2005-06-27 2007-07-10 Biovail Laboratories, Inc. Modified release formulations of a bupropion salt
US9757330B2 (en) 2013-10-18 2017-09-12 Industrial Technology Research Institute Recipe for in-situ gel, and implant, drug delivery system formed thereby

Family Cites Families (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3678149A (en) * 1970-01-26 1972-07-18 Samuel J Prigal Method of enhancing the action of a medicament
US4188373A (en) 1976-02-26 1980-02-12 Cooper Laboratories, Inc. Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4454110A (en) 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4855134A (en) 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
ATE61935T1 (de) * 1985-02-07 1991-04-15 Takeda Chemical Industries Ltd Verfahren zur herstellung von mikrokapseln.
US5690954A (en) * 1987-05-22 1997-11-25 Danbiosyst Uk Limited Enhanced uptake drug delivery system having microspheres containing an active drug and a bioavailability improving material
US5632727A (en) 1988-10-03 1997-05-27 Atrix Laboratories, Inc. Biodegradable film dressing and method for its formation
US4938763B1 (en) 1988-10-03 1995-07-04 Atrix Lab Inc Biodegradable in-situ forming implants and method of producing the same
US5725491A (en) 1988-10-03 1998-03-10 Atrix Laboratories, Inc. Method of forming a biodegradable film dressing on tissue
US5702716A (en) 1988-10-03 1997-12-30 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5324520A (en) 1988-12-19 1994-06-28 Vipont Pharmaceutical, Inc. Intragingival delivery systems for treatment of periodontal disease
US5487897A (en) 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5324519A (en) 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
US5077049A (en) 1989-07-24 1991-12-31 Vipont Pharmaceutical, Inc. Biodegradable system for regenerating the periodontium
AU8935591A (en) 1990-10-30 1992-05-26 Alza Corporation Drug delivery system and method
AU652022B2 (en) * 1991-02-12 1994-08-11 C.R. Bard Inc. Injectable medical device
DE4122591C1 (en) * 1991-07-08 1993-02-18 Roland 8012 Ottobrunn De Bodmeier Producing microcapsules of water insoluble polymer and active agent - includes dissolving or dispersing active agent in aq. polymer contg. gellable assistants
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
US5288502A (en) * 1991-10-16 1994-02-22 The University Of Texas System Preparation and uses of multi-phase microspheres
EP0560014A1 (de) 1992-03-12 1993-09-15 Atrix Laboratories, Inc. Biologisch abbaubarer Wundverband in Form eines Sprühfilms und Verfahren zu seiner Herstellung
JP3235283B2 (ja) * 1993-07-16 2001-12-04 王子製紙株式会社 球状キトサン微粒子の製造方法
US5681873A (en) 1993-10-14 1997-10-28 Atrix Laboratories, Inc. Biodegradable polymeric composition
ATE212830T1 (de) 1993-11-19 2002-02-15 Alkermes Inc Herstellung biologisch abbaubarer, einen biologisch aktiven stoff enthaltender, mikropartikel
EP1125577B1 (de) 1994-04-08 2006-02-15 QLT USA, Inc. Flüssige Zusammensetzungen zur Arzneistoffabgabe
ATE241394T1 (de) 1994-04-08 2003-06-15 Atrix Lab Inc Beigeordnetes polymersystem zur verwendung mit einer medizinischen vorrichtung
US5595760A (en) 1994-09-02 1997-01-21 Delab Sustained release of peptides from pharmaceutical compositions
US5747058A (en) 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5722950A (en) 1995-06-07 1998-03-03 Atrix Laboratories, Inc. Method for remote delivery of an aerosolized liquid
EP1525858A1 (de) * 1995-06-07 2005-04-27 Durect Corporation Kontrolliertes Zuführsystem mit einer Flüssigkeit von hoher Viskosität
US5736152A (en) 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5980945A (en) 1996-01-16 1999-11-09 Societe De Conseils De Recherches Et D'applications Scientifique S.A. Sustained release drug formulations
WO2001044869A1 (en) * 1999-12-16 2001-06-21 Nikon Corporation Bayonet mount
DE50112157D1 (de) * 2000-01-11 2007-04-19 Roland Bodmeier Kit zur implantation enthaltend eine trägerphase und ein lösungsmittel
DE10044545A1 (de) * 2000-09-05 2002-04-04 Roland Bodmeier Retardpartikeldispersion

Also Published As

Publication number Publication date
EP0996426B1 (de) 2007-03-07
DK0996426T3 (da) 2007-07-02
AU8530498A (en) 1998-12-21
PT996426E (pt) 2007-06-18
EP0996426A1 (de) 2000-05-03
ES2284211T3 (es) 2007-11-01
DE59813940D1 (de) 2007-04-19
WO1998055100A1 (de) 1998-12-10
US7303756B1 (en) 2007-12-04

Similar Documents

Publication Publication Date Title
ATE383169T1 (de) Komponente und zusammensetzungen zur verabreichung von wirkstoffen
AU3438900A (en) Use of trehalose for stabilising a liquid vaccine
DK1042355T3 (da) 11beta-halogen-7alfa-substituerede estratriener, fremgangsmåde til fremstilling af farmaceutiske præparater, der indeholder disse 11beta-halogen-7alfa-substituerede estratriener, samt deres anvendelse til fremstilling af lægemidler
WO2002040627A3 (en) Stabilized liquid compositions
PT1137400E (pt) Composicoes contendo um peptideo e um acido polilactico-glicolico apropriado para preparar implantes subscutaneos com um periodo de libertacao prolongado
DE60021038D1 (de) Inhaltsanpassung von Multimedia-Nachrichten
BR9810654B8 (pt) mÉtodo de preparaÇço de um polipeptÍdeo, molÉculas de anticorpo e composiÇço.
HUP0102564A3 (en) Computer application integration system, improved enterprise system, agent-adapter and method for passing messages between computer applications
AU4879396A (en) Use of inorganic aerogels in pharmacy
ATE159284T1 (de) Feuchttigkeitsbeständige zusammensetzung
FI953442A0 (fi) Gonadotropiinia sisältäviä pakastekuivattuja pallosia
HUP0302564A3 (en) Delivery system having encapsulated porous carrier loaded with additives and detergent composition containing the same
TR200002257T2 (tr) Nükleer reseptör ligandları ve ligand bağlanma domainleri.
SE9801536D0 (sv) Kolesterolsänkande komposition
SE9203118D0 (sv) A method of preventing undesired binding in solid phase assays
ATE186738T1 (de) Kohlenhydratmodifizierte cytostatika
DE59813940D1 (de) Multiphasensystem
HUP0004226A3 (en) Novel vitamin d analogues, pharmaceutical compositions containing thereof and process for preparing the same
SG168401A1 (en) Catalyst and use thereof
DE69836999D1 (de) System zur Vorbereitung von Poststücken
DK1235579T3 (da) Farmaceutiske præparater med indhold af trimegeston
DE69720162D1 (de) Behälter aus Copolyester, Copolyesterzusammensetzung dafür und ihre Darstellung
EP0958045A4 (de) Modifizierte poröse stärke
DE69905392D1 (de) Verwendung von einer pharmazeutischen zusammensetzung enthaltende ein antikrebs mittel und mindestens ein peptid
WO1999004316A3 (en) Electrochromic device

Legal Events

Date Code Title Description
EEIH Change in the person of patent owner